Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Net Income (2016 - 2025)

Historic Net Income for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to -$32.2 million.

  • Fate Therapeutics' Net Income rose 3291.47% to -$32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$162.0 million, marking a year-over-year increase of 936.93%. This contributed to the annual value of -$193.0 million for FY2024, which is 1134.46% down from last year.
  • Per Fate Therapeutics' latest filing, its Net Income stood at -$32.2 million for Q3 2025, which was up 3291.47% from -$34.0 million recorded in Q2 2025.
  • Over the past 5 years, Fate Therapeutics' Net Income peaked at -$24.9 million during Q1 2023, and registered a low of -$84.6 million during Q3 2022.
  • For the 5-year period, Fate Therapeutics' Net Income averaged around -$52.0 million, with its median value being -$46.9 million (2024).
  • Per our database at Business Quant, Fate Therapeutics' Net Income plummeted by 10901.28% in 2021 and then surged by 6637.63% in 2023.
  • Over the past 5 years, Fate Therapeutics' Net Income (Quarter) stood at -$69.1 million in 2021, then grew by 10.92% to -$61.5 million in 2022, then grew by 29.05% to -$43.7 million in 2023, then plummeted by 32.55% to -$57.9 million in 2024, then skyrocketed by 44.43% to -$32.2 million in 2025.
  • Its Net Income stands at -$32.2 million for Q3 2025, versus -$34.0 million for Q2 2025 and -$37.9 million for Q1 2025.